One of the primary challenges of CMV is the risk of ventilator-associated complications, such as lung injury or infections like ventilator-associated pneumonia (VAP). These complications can affect patient outcomes and influence epidemiological data on mortality and morbidity rates. Additionally, the need for skilled personnel to operate CMV machines and monitor patients can strain healthcare systems, especially during outbreaks that lead to increased hospital admissions.
